Frontiers in Oncology (Mar 2023)

MACC1-induced migration in tumors: Current state and perspective

  • Tim Hohmann,
  • Urszula Hohmann,
  • Faramarz Dehghani

DOI
https://doi.org/10.3389/fonc.2023.1165676
Journal volume & issue
Vol. 13

Abstract

Read online

Malignant tumors are still a global, heavy health burden. Many tumor types cannot be treated curatively, underlining the need for new treatment targets. In recent years, metastasis associated in colon cancer 1 (MACC1) was identified as a promising biomarker and drug target, as it is promoting tumor migration, initiation, proliferation, and others in a multitude of solid cancers. Here, we will summarize the current knowledge about MACC1-induced tumor cell migration with a special focus on the cytoskeletal and adhesive systems. In addition, a brief overview of several in vitro models used for the analysis of cell migration is given. In this context, we will point to issues with the currently most prevalent models used to study MACC1-dependent migration. Lastly, open questions about MACC1-dependent effects on tumor cell migration will be addressed.

Keywords